Prepping for the Future: HIV PrEP Updates for Managed Care Professionals
Pricing: Free for Members and Non-Members
This activity is supported by independent educational grants from ViiV Healthcare Corporation.
Course Description
Advancements in HIV Pre-Exposure Prophylaxis (PrEP) pharmacotherapy are driven by unmet preventative needs in at-risk patient populations. Though new infections have declined in the U.S. by 8% from 2015 to 2019, HIV continues to demonstrate a disproportionate impact on historically marginalized communities with respect to individual factors such as race, sexual orientation, gender identity, socio-economic status, and more. PrEP therapies demonstrate significant benefit in HIV transmission, and new long-acting therapies introduce adherence advantages. However, several barriers to care still exist in terms of access and adherence.
This session will provide managed care professionals with an overview of existing and emerging pipeline PrEP therapies, insight on the eligibility criteria for PrEP coverage and therapy approaches, and strategies to address health disparities and patient access to care issues.
Target Audience
Pharmacists who practice in managed care settings.
Learning Objectives
At the completion of this activity, participants should be able to:
- Discuss existing CDC PrEP therapy guidelines and treatment benefits and challenges with current management options.
- Identify long-acting PrEP therapies currently in the development pipeline and their potential role in PrEP management.
- Explain at least two differences between existing and new PrEP management options.
- Describe potential access to care issues that might arise in individuals at high risk of contracting HIV.
- Discuss health disparity issues for patients living with HIV and at-risk populations.
Faculty
Kevin N. Astle, PharmD, BCPS, BCACP, AAHIVP, CDCES
Assistant Professor
University of South Florida- Taneja College of Pharmacy
Tampa, FL
Tam C. Phan, PharmD
Assistant Professor of Clinical Pharmacy
USC School of Pharmacy
Los Angeles, CA
Moderator
Vicki Williams, PharmD, BCACP
Field Medical Director
Ionis
Hedgesville, West Virgina
Financial Relationship Disclosures
Faculty/Reviewer/Planner | Reported Relevant Financial Relationships | |
Kevin N. Astle, PharmD, BCPS, BCACP, AAHIVP, CDCES Faculty | Disclosed no relevant financial relationships. | |
Tam C. Phan, PharmD, AAHIVP Faculty | Disclosed no relevant financial relationships. | |
Julie Howard, PharmD |
| |
Brittany V. Henry, PharmD, MBA Planner | Disclosed no relevant financial relationships. |
- If applicable, relevant financial relationships have been mitigated and documented.
- Content has undergone a peer review to ensure content validity.
Accreditation:
The Academy of Managed Care Pharmacy (AMCP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
ACPE UAN:0233-0000-22-051-H02-P • Activity Type: Knowledge-Based
Contact Hours: 1.25
Release Date: October 12, 2022 • Expiration Date: December 31, 2023
Activity Fee: Free for Members and Non-Members
Participants should claim continuing pharmacy education (CPE) credit for this home study activity only if they have not claimed credit for the live activity presented at Nexus 2022. CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor. Please allow 72 hours for processing and posting in your NABP account.
To receive credit for an online activity you must:
- Review the full content of the activity.
- Successfully complete the post-test (required to pass with a score of 70% or higher, it may be taken a maximum of three times).
- Complete a specific activity evaluation.
Available Credit
- 1.25 ACPEThe Academy of Managed Care Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
- 1.25 Certificate of Completion